Concentrum Wealth Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.01M | Buy |
3,991
+162
| +4% | +$37.8K | 0.24% | 47 |
|
|
2026
Q1 | $936K | Buy |
3,829
+1,692
| +79% | +$394K | 0.28% | 41 |
|
|
2025
Q4 | $442K | Buy |
2,137
+23
| +1% | +$4.55K | 0.12% | 56 |
|
|
2025
Q3 | $392K | Buy |
2,114
+87
| +4% | +$14.9K | 0.11% | 53 |
|
|
2025
Q2 | $310K | Buy |
2,027
+11
| +0.5% | +$1.69K | 0.1% | 58 |
|
|
2025
Q1 | $334K | Buy |
2,016
+137
| +7% | +$21.4K | 0.12% | 59 |
|
|
2024
Q4 | $272K | Sell |
1,879
-37
| -2% | -$5.73K | 0.1% | 70 |
|
|
2024
Q3 | $310K | Buy |
1,916
+120
| +7% | +$19.1K | 0.12% | 56 |
|
|
2024
Q2 | $263K | Sell |
1,796
-429
| -19% | -$63.8K | 0.11% | 59 |
|
|
2024
Q1 | $352K | Buy |
2,225
+32
| +1% | +$5.09K | 0.16% | 51 |
|
|
2023
Q4 | $344K | Buy |
2,193
+106
| +5% | +$16.3K | 0.18% | 49 |
|
|
2023
Q3 | $325K | Buy |
2,087
+6
| +0.3% | +$990 | 0.2% | 49 |
|
|
2023
Q2 | $344K | Sell |
2,081
-63
| -3% | -$10.2K | 0.22% | 45 |
|
|
2023
Q1 | $332K | Buy |
2,144
+11
| +0.5% | +$1.78K | 0.25% | 45 |
|
|
2022
Q4 | $377K | Buy |
2,133
+9
| +0.4% | +$1.55K | 0.34% | 47 |
|
|
2022
Q3 | $347K | Buy |
2,124
+10
| +0.5% | +$1.69K | 0.3% | 43 |
|
|
2022
Q2 | $375K | Buy |
2,114
+10
| +0.5% | +$1.78K | 0.31% | 42 |
|
|
2022
Q1 | $373K | Buy |
2,104
+9
| +0.4% | +$1.53K | 0.23% | 47 |
|
|
2021
Q4 | $358K | Buy |
2,095
+376
| +22% | +$61.6K | 0.19% | 48 |
|
|
2021
Q3 | $278K | Buy |
1,719
+9
| +0.5% | +$1.53K | 0.17% | 49 |
|
|
2021
Q2 | $282K | Buy |
1,710
+9
| +0.5% | +$1.49K | 0.18% | 46 |
|
|
2021
Q1 | $279K | Sell |
1,701
-297
| -15% | -$48.1K | 0.21% | 40 |
|
|
2020
Q4 | $314K | Buy |
1,998
+12
| +0.6% | +$1.77K | 0.25% | 36 |
|
|
2020
Q3 | $296K | Buy |
1,986
+12
| +0.6% | +$1.78K | 0.28% | 31 |
|
|
2020
Q2 | $278K | Buy |
1,974
+311
| +19% | +$45.3K | 0.28% | 29 |
|
|
2020
Q1 | $218K | Buy |
1,663
+10
| +0.6% | +$1.42K | 0.29% | 33 |
|
|
2019
Q4 | $241K | Buy |
1,653
+9
| +0.5% | +$1.22K | 0.27% | 39 |
|
|
2019
Q3 | $213K | Buy |
1,644
+7
| +0.4% | +$922 | 0.27% | 40 |
|
|
2019
Q2 | $228K | Buy |
1,637
+9
| +0.6% | +$1.25K | 0.27% | 38 |
|
|
2019
Q1 | $228K | Buy |
1,628
+12
| +0.7% | +$1.61K | 0.3% | 31 |
|
|
2018
Q4 | $209K | Buy |
+1,616
| New | +$225K | 0.36% | 25 |
|
Other funds holding JNJ
Concentrum Wealth Management's JNJ Position: Q2 2026 in Review
Concentrum Wealth Management increased its Johnson & Johnson (JNJ) stake by 4.2% in Q2 2026, buying an estimated $37.8K and bringing the position to 3,991 shares worth $1.01M. The position accounts for 0.24% of the portfolio, ranked #47.
Concentrum Wealth Management first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Concentrum Wealth Management held 3,991 shares of Johnson & Johnson worth $1.01M as of Q2 2026.
- Concentrum Wealth Management bought 162 Johnson & Johnson shares in Q2 2026, an estimated $37.8K.
- Johnson & Johnson made up 0.24% of Concentrum Wealth Management's portfolio in Q2 2026, its #47 holding.
- Concentrum Wealth Management first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Concentrum Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.